Cherenkov Effect Improves Radiation Therapy for Patients with Cancer
February 25, 2015
The characteristic blue glow from a nuclear reactor is present in radiation therapy, too. Investigators from Dartmouth's Norris Cotton Cancer Center, led by Brian W. Pogue, PhD, and PhD candidates Adam K. Glaser and Rongxiao Zhang, published in Physics in Medicine and Biology how the complex parts of the blue light known as the Cherenkov Effect can be measured and used in dosimetry to make therapies safer and more effective.
"The beauty of using the light from the Cherenkov Effect for dosimetry is that it's the only current method that can reveal dosimetric information completely non-invasively in water or tissue," said Glaser.
Although the phenomenon has been constructively utilized for decades in high-energy particle and astrophysics, only recently has it been investigated during radiation therapy. In this study, investigators separately measured emissions of x-ray photons, protons, and electrons and they found widely varying utility.
Based on the findings of where dose correlates with Cherenkov emission, the Dartmouth team concluded that, for x-ray photons, the light emission would be optimally suited for: narrow beam stereotactic radiation therapy and surgery validation studies, verification of dynamic intensity-modulated and volumetric modulated arc therapy treatment plans in water tanks, near mono-energetic sources (e.g., Co-60 and brachy therapy sources), and also for entrance and exit surface imaging dosimetry of both narrow and broad beams. For electron use, Cherenkov emission was found to be only suitable for surface dosimetry applications. Finally, for proton dosimetry, there exists a fundamental lack of Cherenkov emission at the Bragg peak, making the technique of little use, although investigators say that post-irradiation detection of light emission from radioisotopes could prove to be useful.
"By detecting this light, we can pursue novel applications of Cherenkov light emission during radiation therapy to help clinicians improve the overall treatment outcome for patients," explained Pogue.
The collaborators intend to pursue further investigation at Norris Cotton Cancer Center to find other applications where this "free" light can be useful, such as continuing clinical trials in which the Cherenkov light from x-ray beams is imaged directly from a patient's tissue surface during radiation therapy.
Brian W. Pogue, PhD is Professor of Engineering at Dartmouth's Thayer School of Engineering; Professor of Physics & Astronomy at Dartmouth College; and Professor of Surgery at Dartmouth's Geisel School of Medicine. His work in cancer is facilitated by Dartmouth's Norris Cotton Cancer Center in Lebanon, NH. Funding for this project came from the National Institutes of Health R21 EB017559 and Norris Cotton Cancer Center's Prouty pilot funding made possible by the generosity of 1000's of volunteers and donors.
About Norris Cotton Cancer Center at Dartmouth-Hitchcock
Norris Cotton Cancer Center combines advanced cancer research at Dartmouth and the Geisel School of Medicine with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center in Lebanon, NH, at Dartmouth-Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont. It is one of 41 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.